FDA asks sponsors to post missing trial data

The FDA has called on drug developers to publish missing data from thousands of clinical trials, according to reporting in the New York Times. The agency's request targets gaps in publicly available trial results and urges sponsors to make previously unpublished outcomes accessible. The move is framed as an agency push for greater transparency in clinical evidence. (nytimes.com)